Summary
Vascular smooth muscle cells produce and respond to interleukin-1, a cytokine which modifies inflammation-associated vascular activities including the synthesis of extracellular matrix proteins. We have established vascular smooth muscle cells culture conditions in which heparin, in the presence of endothelial cell growth supplement, promotes cell proliferation and inhibits interleukin-1 and matrix protein expression. To test whether interleukin-1 mediates growth and matrix modulation by heparin/endothelial cell growth supplement, vascular smooth muscle cells were transfected with an Epstein-Barr virus-derived expression vector designed to express interleukin-1 antisense transcripts. RNase protection and ELISA assays demonstrated a complete block of interleukin-1 transcription and protein synthesis. Northern blot analysis also showed that interleukin-1 antisense decreased the expression of matrix genes such as type I collagen, fibronectin, and decorin similar to downregulation after heparin/endothelial cell growth supplement treatment. In contrast, the expression of versican was not affected, indicating a selective suppression of matrix proteins. In addition, interleukin-1 antisense significantly prolonged the life span of vascular smooth muscle cells in culture. Our data suggest that heparin/endothelial cell growth supplement induces matrix remodeling and controls growth and senescence of vascular smooth muscle cells through down-regulation of interleukin-1.
Similar content being viewed by others
References
Amento, E. P.; Ehsani, N.; Palmer, H.; Libby, P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11:1223–1230; 1991.
Bakouche, O.; Koff, W. C.; Brown, D. C.; Lachman, L. B. Interleukin 1 release by human monocytes treated with liposome-encapsulated lipopolysaccharide. J. Immunol. 139:1120–1126; 1987.
Beasley, D.; Cohen, R. A.; Levinsky, N. G. Interleukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83:331–335; 1989.
Bernard, M. P.; Kolbe, M.; Weil, D.; Chu, M. L. Human cellular fibronectin: comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions. Biochemistry 24:2698–2704; 1985.
Bitterman, P. B.; Wewers, M. D.; Rennard, S. I.; Adelberg, S.; Crystal, R. G. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 77:700–708; 1986.
Bonin, P. D.; Fici, G. J.; Singh, J. P. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor. Exp. Cell Res. 181:475–482; 1989.
Chu, M. L.; Myers, J. C.; Bernard, M. P.; Ding, J. F.; Ramirez, F. Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res. 10:5925–5934; 1982.
Chung, C. T.; Niemela, S. L.; Miller, R. H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. USA 86:2172–2175; 1989.
Ciolino, H. P.; Vijayagopal, P.; Radhakrishnamurthy, B.; Berenson, G. S. Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while suppressing cellular proliferation [published erratum appears in Atherosclerosis 1993 Mar; 99(2):273]. Atherosclerosis 94:135–146; 1992.
Clowes, A. W.; Clowes, M. M. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab. Invest. 52:611–616; 1985.
Cozzolino, F.; Torcia, M.; Aldinucci, D.; Ziche, M.; Almerigogna, F.; Bani, D.; Stern, D. M. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA 87:6487–6491; 1990.
Daum, G.; Hedin, U.; Wang, Y.; Wang, T.; Clowes, A. W. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ. Res. 81:17–23; 1997.
Dinarello, C. A.; Savage, N. Interleukin-1 and its receptor. Crit. Rev. Immunol. 9:1–20; 1989.
Dinarello, C. A.; Wolff, S. M. The role of interleukin-1 in disease [published erratum appears in N. Engl. J. Med. 1993 Mar 11; 328(10):744]. N. Engl. J. Med. 328:106–113; 1993.
Garfinkel, S.; Brown, S.; Wessendorf, J. H.; Maciag, T. Post-transcriptional regulation of interleukin 1 alpha in various strains of young and senescent human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA. 91:1559–1563; 1994.
Garfinkel, S.; Haines, D. S.; Brown, S.; Wessendorf, J.; Gillespie, D. H.; Maciag, T. Interleukin-1 alpha mediates an alternative pathway for the antiproliferative action of poly(I·C) on human endothelial cells. J. Biol. Chem. 267:24375–24378; 1992.
Garfinkel, S.; Wessendorf, J. H.; Hu, X.; Maciag, T. The human diploid fibroblast senescence pathway is independent of interleukin-1 alpha mRNA levels and tyrosine phosphorylation of FGFR-1 substrates. Biochim. Biophys. Acta 1314:109–119; 1996.
Haskill, S.; Martin, G.; Van Le, L.; Morris, J.; Peace, A.; Bigler, C. F.; Jaffe, G. J.; Hammerberg, C.; Sporn, S. A.; Fong, S., et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88:3681–3685; 1991.
Herbert, J. M.; Bono, F.; Lamarche, I.; Carmeliet, P. The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PA. Thromb. Res. 86:317–324; 1997.
Hoshi, H.; Kan, M.; Chen, J. K.; McKeehan, W. L. Comparative endocrinology-paracrinology-autocrinology of human adult large vessel endothelial and smooth muscle cells. In Vitro Cell. Dev. Biol. 24:309–320; 1988.
Ikeda, U.; Ikeda, M.; Oohara, T.; Kano, S.; Yaginuma, T. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 84:183–188; 1990.
Kato, S.; Muraishi, A.; Miyamoto, T.; Fox, J. C. Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells. In Vitro Cell. Dev. Biol. Anim. 34:341–346; 1998.
Kenagy, R. D.; Clowes, A. W. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors. Thromb. Res. 77:55–61; 1995.
Kenagy, R. D.; Nikkari, S. T.; Welgus, H. G.; Clowes, A. W. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J. Clin. Invest. 93:1987–1993; 1994.
Kennedy, S. H.; Qin, H.; Lin, L.; Tan, E. M. Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am. J. Pathol. 146:764–771; 1995.
Kumar, S.; Tomooka, Y.; Noda, M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185:1155–1161; 1992.
Leung, K.; Betts, J. C.; Xu, L.; Nabel, G. J. The cytoplasmic domain of the interleukin-1 receptor is required for nuclear factor-kappa B signal transduction. J. Biol. Chem. 269:1579–1582; 1994.
Libby, P.; Ordovas, J. M.; Birinyi, L. K.; Auger, K. R.; Dinarello, C. A. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J. Clin. Invest. 78:1432–1438; 1986.
Libby, P.; Warner, S. J.; Friedman, G. B. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81:487–498; 1988.
Libby, P.; Wyler, D. J.; Janicka, M. W.; Dinarello, C. A. Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis. 5:186–191; 1985.
Loidl, H. R.; Brinker, J. M.; May, M.; Pihlajaniemi, T.; Morrow, S.; Rosenbloom, J.; Myers, J. C. Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. Nucleic Acids Res. 12:9383–9394; 1984.
Loppnow, H.; Bil, R.; Hirt, S.; Schonbeck, U.; Herzberg, M.; Werdan, K.; Rietschel, E. T.; Brandt, E.; Flad, H. D. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91:134–141; 1998.
Loppnow, H.; Libby, P. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp. Cell Res. 198:283–290; 1992.
Lyons-Giordano, B.; Brinker, J. M.; Kefalides, N. A. Heparin increases mRNA levels of thrombospondin but not fibronectin in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 162:1100–1104; 1989.
Lyons-Giordano, B.; Conaway, H.; Kefalides, N. A. The effect of heparin on fibronectin and thrombospondin synthesis by human smooth muscle cells. Biochem. Biophys. Res. Commun. 148:1264–1269; 1987.
Maciag, T.; Cerundolo, J.; Ilsley, S.; Kelley, P. R.; Forand, R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. Proc. Natl. Acad. Sci. USA 76:5674–5678; 1979.
Maier, J. A.; Voulalas, P.; Roeder, D.; Maciag, T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science (Wash DC) 249:1570–1574; 1990.
Majack, R. A.; Bornstein, P. Regulation of collagen biosynthesis. Heparin alters the biosynthetic phenotype of vascular smooth muscle cells. Ann. NY Acad. Sci. 460:172–180; 1985.
Majack, R. A.; Clowes, A. W. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J. Cell. Physiol. 118:253–256; 1984.
Majors, A.; Ehrhart, L. A. Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cell cultures. Arterioscler. Thromb. 13:680–686; 1993.
Muegge, K.; Williams, T. M.; Kant, J.; Karin, M.; Chiu, R.; Schmidt, A.; Siebenlist, U.; Young, H. A.; Durum, S. K. Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1. Science (Wash DC) 246:249–251; 1989.
Mueller, S. N.; Thomas, K. A.; Di Salvo, J.; Levine, E. M. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro. J. Cell. Physiol. 140:439–448; 1989.
Reid, G. G.; Lackie, J. M.; Gorham, S. D. The behaviour of BHK cells and neutrophil leukocytes on collagen gels of defined mechanical strength. Cell Biol. Int. Rep. 14:1033–1045; 1990.
Reid, G. G.; Newman, I. Human leucocyte migration through collagen matrices containing other extracellular matrix components. Cell Biol. Int. Rep. 15:711–720; 1991.
Rubartelli, A.; Cozzolino, F.; Talio, M.; Sitia, R. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9:1503–1510; 1990.
Schmidt, J. A.; Mizel, S. B.; Cohen, D.; Green, I. Interleukin 1, a potential regulator of fibroblast proliferation. J. Immunol. 128:2177–2182; 1982.
Shirakawa, F.; Mizel, S. B. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424–2430; 1989.
Sorger, T.; Friday, N.; Yang, L. D.; Levine, E. M. Heparin and the phenotype of adult human vascular smooth muscle cells. In Vitro Cell. Dev. Biol. Anim. 31:671–683; 1995.
Sorger, T.; Plank, B.; Tan, E.; Levine, E. Heparin and the phenotype of adult human arterial smooth muscle cells in the presence of heparin. J. Cell Biol. 109:331a; 1989.
Tajima, S.; Wachi, H.; Takehana, M. Post-translational regulation of type I collagen synthesis by heparin in vascular smooth muscle cells. J. Biochem. 117:353–358; 1995.
Tan, E. M.; Dodge, G. R.; Sorger, T.; Kovalszky, I.; Unger, G. A.; Yang, L.; Levine, E. M.; Iozzo, R. V. Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells. Lab. Invest. 64:474–482; 1991.
Tan, E. M.; Levine, E.; Sorger, T.; Unger, G. A.; Hacobian, N.; Planck, B.; Iozzo, R. V. Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells. Biochem. Biophys. Res. Commun. 163:84–92; 1989.
Tokunaga, K.; Nakamura, Y.; Sakata, K.; Fujimori, K.; Ohkubo, M.; Sawada, K.; Sakiyama, S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47:5616–5619; 1987.
Utoguchi, N.; Mizuguchi, H.; Dantakean, A.; Makimoto, H.; Wakai, Y.; Tsutsumi, Y.; Nakagawa, S.; Mayumi, T. Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br. J. Cancer 73:24–28; 1996.
Wachi, H.; Seyama, Y.; Tajima, S. Modulation of elastin expression by heparin is dependent on the growth condition of vascular smooth muscle cells: up-regulation of elastin expression by heparin in the proliferating cells is mediated by the inhibition of protein kinase C activity. J. Biochem. 118:582–586; 1995.
Warner, S. J.; Auger, K. R.; Libby, P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 165:1316–1331; 1987.
Wessendorf, J. H.; Garfinkel, S.; Zhan, X.; Brown, S.; Maciag, T. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. J. Biol. Chem. 268:22100–22104; 1993.
Wight, T. N.; Hascall, V. C. Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture. J. Cell Biol. 96:167–176; 1983.
Williams, S. P.; Mason, R. M. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin. Arch. Biochem. Biophys. 287:386–396; 1991.
Zoellner, H.; Filonzi, E. L.; Stanton, H. R.; Layton, J. E.; Hamilton, J. A. Human arterial smooth muscle cells synthesize granulocyte colony-stimulating factor in response to interleukin-1 alpha and tumor necrosis factor-alpha. Blood 80:2805–2810; 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hsu, JY., Hsu, MY., Sorger, T. et al. Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1. In Vitro Cell.Dev.Biol.-Animal 35, 647–654 (1999). https://doi.org/10.1007/s11626-999-0105-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-999-0105-6